Alfred Altomari's Net Worth
$5.81 Million
Who is Alfred Altomari?
Alfred Altomari has an estimated net worth of $5.81 Million. This is based on reported shares across multiple companies, which include BARRIER THERAPEUTICS INC, INSMED Inc, AGILE THERAPEUTICS INC, Recro Pharma, Inc., Baudax Bio, Inc., DUSA PHARMACEUTICALS INC, and AUXILIUM PHARMACEUTICALS INC.
SEC CIK
Alfred Altomari's CIK is 0001285644
Past Insider Trading and Trends
2019 was Alfred Altomari's most active year for acquiring shares with 11 total transactions. Alfred Altomari's most active month to acquire stocks was the month of April. 2019 was Alfred Altomari's most active year for disposing of shares, totalling 5 transactions. Alfred Altomari's most active month to dispose stocks was the month of July. 2020 saw Alfred Altomari paying a total of $310,337.85 for 1,106,597 shares, this is the most they've acquired in one year. In 2020 Alfred Altomari cashed out on 181,140 shares for a total of $791,400.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
BARRIER THERAPEUTICS INC No price found
Chief Executive Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -62.11K |
$4.15 | -$257,739.90 |
0
|
Aug 5 - Aug 6
| |||
Form 4
| +37.93% | 16.67K |
$3.35 | $55,834.45 | 60.61K |
Mar 14
| |||
Form 4
| +57.34% | 15K |
$6.87 | $103,050.00 | 41.16K |
Apr 3
| |||
Form 4
| +778.94% | 22.08K |
$7.43 | $164,076.69 | 24.92K |
Dec 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
INSMED Inc (INSM) Snapshot price: $71.04
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +23.36% | 13.16K |
—
|
—
| 69.5K |
May 13
| |||
Form 4
| +30.58% | 13.19K |
—
|
—
| 56.33K |
May 11
| |||
Form 4
| +51.39% | 14.64K |
—
|
—
| 43.14K |
May 11
| |||
Form 4
| +36.10% | 7.56K |
—
|
—
| 28.5K |
May 12
| |||
Form 4
| -48.85% | -20.00K |
$39.57 | -$791,400.00 | 20.94K |
Scheduled
|
Dec 7
| ||
Form 4
| +24.66% | 8.1K |
—
|
—
| 40.94K |
May 12
| |||
Form 4
| +26.59% | 6.9K |
—
|
—
| 32.84K |
May 15
| |||
Form 4
| -17.49% | -5.50K |
$30.00 | -$165,000.00 | 25.94K |
Scheduled
|
Feb 26
| ||
Form 4
| -14.89% | -5.50K |
$27.50 | -$151,250.00 | 31.44K |
Scheduled
|
Feb 15
| ||
Form 4
| -12.96% | -5.50K |
$25.00 | -$137,500.00 | 36.94K |
Scheduled
|
Feb 5
| ||
Form 4
| -11.47% | -5.50K |
$22.50 | -$123,750.00 | 42.44K |
Scheduled
|
Jan 10
| ||
Form 4
| +14.49% | 6.07K |
—
|
—
| 47.94K |
May 15
| |||
Form 4
| +19.05% | 6.7K |
—
|
—
| 41.88K |
May 17
| |||
Form 4
| +56.80% | 12.74K |
—
|
—
| 35.17K |
May 19
| |||
Form 4
| +38.38% | 6.22K |
—
|
—
| 22.43K |
Jan 8
| |||
Form 4
| +274.62% | 11.88K |
—
|
—
| 16.21K |
Jan 10 - Jan 11
| |||
Form 4
|
∞
| 4.33K |
—
|
—
| 4.33K |
Aug 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 11
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
AGILE THERAPEUTICS INC (AGRX) Snapshot price: $1.49
Chief Executive Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -47.75K |
$1.52 | -$72,578.48 |
0
|
Aug 26
| |||
Form 4
| +3,612.99% | 46.46K |
—
|
—
| 47.75K |
Jun 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 9
| |||
Form 4
| +348.60% | 50K |
$0.45 | $22,500.00 | 64.34K |
Aug 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 19
| |||
Form 4
| +11.42% | 58.82K |
—
|
—
| 573.73K |
Oct 13
| |||
Form 4
| +5.36% | 26.2K |
$1.26 | $33,095.84 | 514.91K |
Jul 29
| |||
Form 4
| +4.27% | 20K |
$1.61 | $32,200.00 | 488.71K |
May 18
| |||
Form 4
| +2.74% | 12.5K |
$2.00 | $25,030.00 | 468.71K |
Mar 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 27
| |||
Form 4
| +26.16% | 94.6K |
$1.76 | $166,494.24 | 456.21K |
Aug 20
| |||
Form 4
| +16.05% | 50K |
$1.76 | $88,000.00 | 361.61K |
Jun 22
| |||
Form 4
| +9.31% | 26.54K |
$1.46 | $38,844.11 | 311.61K |
Feb 27
| |||
Form 4
| +10.25% | 26.5K |
—
|
—
| 285.07K |
Jan 22
| |||
Form 4
| +8.38% | 20K |
$1.27 | $25,400.00 | 258.57K |
Jun 10
| |||
Form 4/A
| +11.71% | 25K |
$1.54 | $38,500.00 | 238.57K |
Mar 25
| |||
Form 4
| +11.71% | 25K |
$1.54 | $38,500.00 | 238.57K |
Mar 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 29
| |||
Form 4
| +19.81% | 35.31K |
—
|
—
| 213.57K |
Jan 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 20
| |||
Form 4
| +10.31% | 16.67K |
—
|
—
| 178.25K |
Feb 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 24
| |||
Form 4
| +6.60% | 10K |
$3.34 | $33,400.00 | 161.59K |
Aug 25
| |||
Form 4
| +7.06% | 10K |
$3.51 | $35,100.00 | 151.59K |
May 11
| |||
Form 4
| +26.88% | 30K |
$1.76 | $52,800.00 | 141.59K |
Apr 11
| |||
Form 4
| +17.56% | 16.67K |
—
|
—
| 111.59K |
Feb 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 25
| |||
Form 4
| +21.30% | 16.67K |
—
|
—
| 94.92K |
Feb 8
| |||
Form 4
| +3.30% | 2.5K |
$8.73 | $21,825.00 | 78.25K |
Jun 2
| |||
Form 4
| +30.04% | 17.5K |
$1.76 | $30,800.00 | 75.75K |
Mar 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 19
| |||
Form 4
| +106.18% | 30K |
$1.76 | $52,800.00 | 58.25K |
Dec 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 24
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Recro Pharma, Inc. (SCTL) No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +52.86% | 15.28K |
—
|
—
| 44.2K |
Dec 5
| |||
Form 4
| +37.96% | 7.96K |
—
|
—
| 28.91K |
May 9
| |||
Form 4
| +172.77% | 13.27K |
—
|
—
| 20.96K |
May 12
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
May 4
| |||
Form 4
| +412.20% | 6.18K |
—
|
—
| 7.68K |
May 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 12
| |||
Form 4
|
∞
| 1.5K |
$6.55 | $9,825.00 | 1.5K |
Dec 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 12
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Baudax Bio, Inc. (BXRX) Snapshot price: $0.02
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +92.04% | 56.45K |
—
|
—
| 117.78K |
Apr 7
| |||
Form 4
| +8.88% | 5K |
$1.06 | $5,299.50 | 61.33K |
Nov 23
| |||
Form 4
| +68.75% | 22.95K |
—
|
—
| 56.33K |
May 6
| |||
Form 4
| +17.62% | 5K |
$2.34 | $11,700.00 | 33.38K |
Mar 26
| |||
Form 4
| +238.61% | 20K |
—
|
—
| 28.38K |
Dec 5
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||